| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 1.11e-09 | 130 | 50 | 8 | GO:0005200 | |
| GeneOntologyMolecularFunction | GTP binding | 5.40e-07 | 397 | 50 | 9 | GO:0005525 | |
| GeneOntologyMolecularFunction | guanyl ribonucleotide binding | 1.25e-06 | 439 | 50 | 9 | GO:0032561 | |
| GeneOntologyMolecularFunction | guanyl nucleotide binding | 1.25e-06 | 439 | 50 | 9 | GO:0019001 | |
| GeneOntologyMolecularFunction | structural molecule activity | TUBA1B PXDN TUBA1A TUBA3D TUBA1C TUBA3E TUBA8 TUBA4A TUBA3C VCL | 6.02e-05 | 891 | 50 | 10 | GO:0005198 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | 8.30e-04 | 446 | 50 | 6 | GO:0004674 | |
| GeneOntologyMolecularFunction | cadherin binding | 1.55e-03 | 339 | 50 | 5 | GO:0045296 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | 2.09e-03 | 363 | 50 | 5 | GO:0106310 | |
| GeneOntologyMolecularFunction | kinase activity | 2.78e-03 | 764 | 50 | 7 | GO:0016301 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle | TUBA1B PTPN3 STAG1 TUBA1A CAMK2A TUBA3D TUBA1C PPME1 TUBA3E E4F1 TUBA8 TUBA4A TUBA3C | 5.90e-07 | 1014 | 50 | 13 | GO:0000278 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | TUBA1B STAG1 TUBA1A TUBA3D TUBA1C TUBA3E TUBA8 TUBA4A TUBA3C | 5.08e-05 | 720 | 50 | 9 | GO:0000226 |
| GeneOntologyCellularComponent | microtubule | 4.21e-06 | 533 | 50 | 9 | GO:0005874 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | TUBA1B TPT1 TUBA1A TUBA3D TUBA1C TUBA3E TUBA8 TUBA4A TUBA3C VCL | 4.42e-05 | 899 | 50 | 10 | GO:0099513 |
| GeneOntologyCellularComponent | cytoplasmic microtubule | 2.87e-04 | 133 | 50 | 4 | GO:0005881 | |
| GeneOntologyCellularComponent | supramolecular fiber | TUBA1B TPT1 TUBA1A TUBA3D TUBA1C TUBA3E TUBA8 TUBA4A TUBA3C VCL | 4.08e-04 | 1179 | 50 | 10 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | TUBA1B TPT1 TUBA1A TUBA3D TUBA1C TUBA3E TUBA8 TUBA4A TUBA3C VCL | 4.30e-04 | 1187 | 50 | 10 | GO:0099081 |
| Domain | Alpha_tubulin | 1.96e-17 | 9 | 49 | 7 | IPR002452 | |
| Domain | Tubulin_C | 9.05e-14 | 22 | 49 | 7 | SM00865 | |
| Domain | Tubulin_C | 9.05e-14 | 22 | 49 | 7 | PF03953 | |
| Domain | Tubulin/FtsZ_2-layer-sand-dom | 9.05e-14 | 22 | 49 | 7 | IPR018316 | |
| Domain | Tubulin_C | 1.30e-13 | 23 | 49 | 7 | IPR023123 | |
| Domain | TUBULIN | 1.30e-13 | 23 | 49 | 7 | PS00227 | |
| Domain | Tubulin | 1.30e-13 | 23 | 49 | 7 | IPR000217 | |
| Domain | Tub_FtsZ_C | 1.30e-13 | 23 | 49 | 7 | IPR008280 | |
| Domain | Tubulin | 1.30e-13 | 23 | 49 | 7 | SM00864 | |
| Domain | Tubulin_CS | 1.30e-13 | 23 | 49 | 7 | IPR017975 | |
| Domain | Tubulin_FtsZ_GTPase | 1.83e-13 | 24 | 49 | 7 | IPR003008 | |
| Domain | Tubulin | 1.83e-13 | 24 | 49 | 7 | PF00091 | |
| Domain | - | 8.95e-12 | 20 | 49 | 6 | 3.30.1330.20 | |
| Domain | - | 1.25e-11 | 21 | 49 | 6 | 1.10.287.600 | |
| Domain | - | 1.72e-11 | 22 | 49 | 6 | 3.40.50.1440 | |
| Domain | PROTEIN_KINASE_ATP | 1.22e-03 | 459 | 49 | 6 | PS00107 | |
| Domain | PROTEIN_KINASE_DOM | 1.75e-03 | 493 | 49 | 6 | PS50011 | |
| Domain | Kinase-like_dom | 2.82e-03 | 542 | 49 | 6 | IPR011009 | |
| Domain | Protein_kinase_ATP_BS | 3.07e-03 | 379 | 49 | 5 | IPR017441 | |
| Domain | Pkinase | 3.14e-03 | 381 | 49 | 5 | PF00069 | |
| Domain | Prot_kinase_dom | 8.91e-03 | 489 | 49 | 5 | IPR000719 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPG_TO_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 3.81e-17 | 17 | 39 | 8 | M47768 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_DCTN1_TO_RETROGRADE_AXONAL_TRANSPORT | 6.84e-17 | 18 | 39 | 8 | M47753 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_IRON_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.18e-16 | 19 | 39 | 8 | M47818 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_ZN_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.18e-16 | 19 | 39 | 8 | M47813 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_MICROTUBULE_ATTACHMENT | 1.96e-16 | 20 | 39 | 8 | M47890 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION_AT_THE_MINUS_ENDS | 1.96e-16 | 20 | 39 | 8 | M47911 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 3.16e-16 | 21 | 39 | 8 | M27067 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 3.16e-16 | 21 | 39 | 8 | M47767 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PROMOTION_OF_MICROTUBULE_GROWTH | 4.96e-16 | 22 | 39 | 8 | M47903 | |
| Pathway | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | 7.59e-16 | 23 | 39 | 8 | M19135 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION | 7.59e-16 | 23 | 39 | 8 | M47910 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_FIBER_ORGANIZATION | 7.59e-16 | 23 | 39 | 8 | M47900 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTEROGRADE_AXONAL_TRANSPORT | 1.14e-15 | 24 | 39 | 8 | M47671 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.14e-15 | 24 | 39 | 8 | M47700 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SIFA_TO_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 1.67e-15 | 25 | 39 | 8 | M47775 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.67e-15 | 25 | 39 | 8 | M47710 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | TUBA1B TUBA1A CAMK2A TUBA3D TUBA1C TUBA3E TUBA8 TUBA4A TUBA3C | 2.32e-15 | 44 | 39 | 9 | M27934 |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ANTEROGRADE_AXONAL_TRANSPORT | 2.40e-15 | 26 | 39 | 8 | M47672 | |
| Pathway | REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC | 2.40e-15 | 26 | 39 | 8 | M9648 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_NUCLEATION | 4.76e-15 | 28 | 39 | 8 | M47898 | |
| Pathway | REACTOME_ACTIVATION_OF_AMPK_DOWNSTREAM_OF_NMDARS | 6.56e-15 | 29 | 39 | 8 | M27948 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 1.60e-14 | 32 | 39 | 8 | M29848 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 1.60e-14 | 32 | 39 | 8 | M27491 | |
| Pathway | REACTOME_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING | 2.11e-14 | 33 | 39 | 8 | M27297 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BRANCHING_MICROTUBULE_NUCLEATION | 2.11e-14 | 33 | 39 | 8 | M47901 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ARL8_REGULATED_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 3.56e-14 | 35 | 39 | 8 | M47774 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 7.35e-14 | 38 | 39 | 8 | M14981 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 2.16e-13 | 43 | 39 | 8 | M47669 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RAB7_REGULATED_MICROTUBULE_MINUS_END_DIRECTED_TRANSPORT | 2.16e-13 | 43 | 39 | 8 | M47773 | |
| Pathway | WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY | TUBA1B TUBA1A TUBA3D TUBA1C TUBA3E TUBA8 TUBA4A TUBA3C FBXW7 | 2.32e-13 | 71 | 39 | 9 | M39690 |
| Pathway | REACTOME_AGGREPHAGY | 2.63e-13 | 44 | 39 | 8 | M29830 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 3.20e-13 | 45 | 39 | 8 | M47670 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 3.86e-13 | 46 | 39 | 8 | M27828 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 6.63e-13 | 49 | 39 | 8 | M891 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 9.33e-13 | 51 | 39 | 8 | M26972 | |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 1.29e-12 | 53 | 39 | 8 | M27651 | |
| Pathway | WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 1.77e-12 | 55 | 39 | 8 | M39613 | |
| Pathway | KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 2.06e-12 | 56 | 39 | 8 | M2333 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 2.39e-12 | 57 | 39 | 8 | M27251 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | TUBA1B TUBA1A CAMK2A TUBA3D TUBA1C TUBA3E TUBA8 TUBA4A TUBA3C | 3.17e-12 | 94 | 39 | 9 | M2843 |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 3.63e-12 | 17 | 39 | 6 | MM14731 | |
| Pathway | REACTOME_KINESINS | 4.23e-12 | 61 | 39 | 8 | M977 | |
| Pathway | REACTOME_PROTEIN_FOLDING | TUBA1B TUBA1A TUBA3D TUBA1C TUBA3E TUBA8 TUBA4A TUBA3C FBXW7 | 4.65e-12 | 98 | 39 | 9 | M776 |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 6.72e-12 | 102 | 39 | 9 | M27648 | |
| Pathway | REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE | 1.68e-11 | 72 | 39 | 8 | M26954 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 2.63e-11 | 76 | 39 | 8 | M27215 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 2.63e-11 | 76 | 39 | 8 | M48037 | |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 3.62e-11 | 79 | 39 | 8 | M27743 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | TUBA1B STAG1 TUBA1A TUBA3D TUBA1C TUBA3E TUBA8 TUBA4A TUBA3C | 4.95e-11 | 127 | 39 | 9 | M27181 |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 8.50e-11 | 27 | 39 | 6 | MM15549 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 8.50e-11 | 27 | 39 | 6 | MM15674 | |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | 1.05e-10 | 90 | 39 | 8 | M29841 | |
| Pathway | KEGG_GAP_JUNCTION | 1.05e-10 | 90 | 39 | 8 | M4013 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 1.36e-10 | 29 | 39 | 6 | MM15219 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 1.63e-10 | 95 | 39 | 8 | M6729 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 2.48e-10 | 100 | 39 | 8 | M27650 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 2.58e-10 | 32 | 39 | 6 | MM14730 | |
| Pathway | REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT | 3.15e-10 | 156 | 39 | 9 | M27097 | |
| Pathway | REACTOME_AGGREPHAGY | 5.49e-10 | 36 | 39 | 6 | MM15669 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 6.55e-10 | 37 | 39 | 6 | MM15102 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | DOCK3 TUBA1B TUBA1A TUBA3D TUBA1C TUBA3E TUBA8 TUBA4A TUBA3C | 6.78e-10 | 170 | 39 | 9 | M941 |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 1.15e-09 | 121 | 39 | 8 | M872 | |
| Pathway | REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION | 1.58e-09 | 187 | 39 | 9 | M961 | |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | 1.59e-09 | 126 | 39 | 8 | M705 | |
| Pathway | BIOCARTA_MTA3_PATHWAY | 1.87e-09 | 20 | 39 | 5 | MM1383 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | TUBA1B STAG1 TUBA1A TUBA3D TUBA1C TUBA3E TUBA8 TUBA4A TUBA3C | 1.90e-09 | 191 | 39 | 9 | M29614 |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 1.96e-09 | 44 | 39 | 6 | MM14606 | |
| Pathway | REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT | 2.59e-09 | 134 | 39 | 8 | M27751 | |
| Pathway | REACTOME_MITOTIC_G2_G2_M_PHASES | TUBA1B TUBA1A TUBA3D TUBA1C PPME1 TUBA3E TUBA8 TUBA4A TUBA3C | 2.85e-09 | 200 | 39 | 9 | M864 |
| Pathway | REACTOME_HCMV_EARLY_EVENTS | 3.28e-09 | 138 | 39 | 8 | M29805 | |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 3.38e-09 | 48 | 39 | 6 | MM15353 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | TUBA1B STAG1 TUBA1A TUBA3D TUBA1C TUBA3E TUBA8 TUBA4A TUBA3C | 3.40e-09 | 204 | 39 | 9 | M4217 |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | TUBA1B TUBA1A CAMK2A TUBA3D TUBA1C TUBA3E TUBA8 TUBA4A TUBA3C | 3.54e-09 | 205 | 39 | 9 | M752 |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 3.67e-09 | 140 | 39 | 8 | M27550 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 5.56e-09 | 52 | 39 | 6 | MM14949 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 6.68e-09 | 151 | 39 | 8 | M550 | |
| Pathway | REACTOME_INTRAFLAGELLAR_TRANSPORT | 7.03e-09 | 54 | 39 | 6 | M27482 | |
| Pathway | REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION | TUBA1B TUBA1A USO1 TUBA3D TUBA1C TUBA3E TUBA8 GMPPA TUBA4A TUBA3C | 7.53e-09 | 307 | 39 | 10 | M894 |
| Pathway | REACTOME_AUTOPHAGY | 9.55e-09 | 158 | 39 | 8 | M27935 | |
| Pathway | REACTOME_KINESINS | 9.81e-09 | 57 | 39 | 6 | MM15714 | |
| Pathway | REACTOME_HCMV_INFECTION | 1.16e-08 | 162 | 39 | 8 | M29804 | |
| Pathway | REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE | TUBA1B STAG1 TUBA1A TUBA3D TUBA1C TUBA3E TUBA8 TUBA4A TUBA3C | 1.21e-08 | 236 | 39 | 9 | M27185 |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 1.82e-08 | 110 | 39 | 7 | MM15350 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 2.41e-08 | 66 | 39 | 6 | MM17074 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 2.90e-08 | 68 | 39 | 6 | MM14921 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 2.90e-08 | 68 | 39 | 6 | MM14968 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | TUBA1B TUBA1A CAMK2A TUBA3D TUBA1C TUBA3E TUBA8 TUBA4A TUBA3C | 3.89e-08 | 270 | 39 | 9 | M15514 |
| Pathway | REACTOME_INTERFERON_SIGNALING | TUBA1B TUBA1A CAMK2A TUBA3D TUBA1C TUBA3E TUBA8 TUBA4A TUBA3C | 4.28e-08 | 273 | 39 | 9 | M983 |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 4.46e-08 | 73 | 39 | 6 | MM15491 | |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | 4.46e-08 | 73 | 39 | 6 | MM15672 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 5.50e-08 | 129 | 39 | 7 | MM14894 | |
| Pathway | REACTOME_CILIUM_ASSEMBLY | 6.26e-08 | 201 | 39 | 8 | M27472 | |
| Pathway | REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC | 6.76e-08 | 203 | 39 | 8 | M27654 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | 8.76e-08 | 138 | 39 | 7 | MM15635 | |
| Pathway | REACTOME_M_PHASE | TUBA1B STAG1 TUBA1A USO1 TUBA3D TUBA1C TUBA3E TUBA8 TUBA4A TUBA3C | 1.36e-07 | 417 | 39 | 10 | M27662 |
| Pathway | REACTOME_SIGNALING_BY_HEDGEHOG | 1.55e-07 | 150 | 39 | 7 | M27440 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 1.58e-07 | 90 | 39 | 6 | MM14979 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 2.04e-07 | 94 | 39 | 6 | MM14515 | |
| Pathway | REACTOME_CELL_CYCLE_MITOTIC | TUBA1B STAG1 TUBA1A USO1 TUBA3D TUBA1C PPME1 TUBA3E TUBA8 TUBA4A TUBA3C | 2.18e-07 | 561 | 39 | 11 | M5336 |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 2.62e-07 | 98 | 39 | 6 | MM15352 | |
| Pubmed | 9.10e-23 | 9 | 50 | 8 | 21167302 | ||
| Pubmed | 7.56e-19 | 19 | 50 | 8 | 15691386 | ||
| Pubmed | 7.56e-19 | 19 | 50 | 8 | 15698476 | ||
| Pubmed | 3.19e-18 | 22 | 50 | 8 | 28117675 | ||
| Pubmed | Histone deacetylase 6 regulates human immunodeficiency virus type 1 infection. | 1.81e-16 | 8 | 50 | 6 | 16148047 | |
| Pubmed | Systematic Analysis of the Functions of Lysine Acetylation in the Regulation of Tat Activity. | 1.37e-15 | 22 | 50 | 7 | 23826228 | |
| Pubmed | The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis. | 5.94e-15 | 12 | 50 | 6 | 15331610 | |
| Pubmed | HIV-1 rev depolymerizes microtubules to form stable bilayered rings. | 1.10e-14 | 13 | 50 | 6 | 10908577 | |
| Pubmed | 1.93e-14 | 14 | 50 | 6 | 12486001 | ||
| Pubmed | The N-terminal domain of c-Myc associates with alpha-tubulin and microtubules in vivo and in vitro. | 3.00e-14 | 6 | 50 | 5 | 7651436 | |
| Pubmed | 3.00e-14 | 6 | 50 | 5 | 16327313 | ||
| Pubmed | 3.00e-14 | 6 | 50 | 5 | 3785200 | ||
| Pubmed | 1.05e-13 | 7 | 50 | 5 | 11146551 | ||
| Pubmed | 4.74e-13 | 22 | 50 | 6 | 15103018 | ||
| Pubmed | Interaction between metabotropic glutamate receptor 7 and alpha tubulin. | 6.27e-13 | 9 | 50 | 5 | 11953448 | |
| Pubmed | 3.78e-12 | 4 | 50 | 4 | 18400243 | ||
| Pubmed | 3.05e-11 | 17 | 50 | 5 | 17360745 | ||
| Pubmed | 1.32e-10 | 7 | 50 | 4 | 36681692 | ||
| Pubmed | 7.20e-10 | 212 | 50 | 8 | 23463506 | ||
| Pubmed | 2.80e-09 | 3 | 50 | 3 | 11121746 | ||
| Pubmed | Tubulin and FtsZ structures: functional and therapeutic implications. | 2.80e-09 | 3 | 50 | 3 | 9722999 | |
| Pubmed | 2.80e-09 | 3 | 50 | 3 | 11163133 | ||
| Pubmed | 4.79e-09 | 94 | 50 | 6 | 36584595 | ||
| Pubmed | TUBA1B TUBA1A USO1 HPRT1 TUBA1C EIF5 PPME1 TUBA3E GMPPA TUBA4A TUBA3C | 3.79e-08 | 878 | 50 | 11 | 37223481 | |
| Pubmed | 5.15e-08 | 239 | 50 | 7 | 23246001 | ||
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | TUBA1B ACACA STAG1 TUBA1A USO1 HPRT1 EIF5 OSGEP GMPPA TUBA4A | 5.37e-08 | 704 | 50 | 10 | 29955894 |
| Pubmed | 5.57e-08 | 6 | 50 | 3 | 10840040 | ||
| Pubmed | 5.57e-08 | 6 | 50 | 3 | 18613978 | ||
| Pubmed | 5.57e-08 | 6 | 50 | 3 | 12090300 | ||
| Pubmed | CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer. | 1.83e-07 | 288 | 50 | 7 | 31501420 | |
| Pubmed | 2.33e-07 | 9 | 50 | 3 | 19103752 | ||
| Pubmed | Proteomic dissection of the von Hippel-Lindau (VHL) interactome. | 3.07e-07 | 98 | 50 | 5 | 21942715 | |
| Pubmed | Dysferlin interacts with tubulin and microtubules in mouse skeletal muscle. | 4.58e-07 | 11 | 50 | 3 | 20405035 | |
| Pubmed | 7.92e-07 | 13 | 50 | 3 | 14697242 | ||
| Pubmed | 8.29e-07 | 50 | 50 | 4 | 23703321 | ||
| Pubmed | Quantitative interactome proteomics identifies a proteostasis network for GABAA receptors. | 1.03e-06 | 125 | 50 | 5 | 36030824 | |
| Pubmed | Channel-interacting PDZ protein, 'CIPP', interacts with proteins involved in cytoskeletal dynamics. | 1.55e-06 | 16 | 50 | 3 | 19138174 | |
| Pubmed | TUBA1B TPT1 PXDN ACACA RSL1D1 HPRT1 EIF5 SRPK1 OSGEP KLHDC10 TUBA4A | 1.82e-06 | 1297 | 50 | 11 | 33545068 | |
| Pubmed | Structural features and restricted expression of a human alpha-tubulin gene. | 2.03e-06 | 2 | 50 | 2 | 3839072 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 22296162 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 10512679 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 25328666 | ||
| Pubmed | Acetylated α-tubulin is reduced in individuals with poor sperm motility. | 2.03e-06 | 2 | 50 | 2 | 24268707 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 12054644 | ||
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 2.52e-06 | 271 | 50 | 6 | 32433965 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 3.38e-06 | 861 | 50 | 9 | 36931259 | |
| Pubmed | 3.65e-06 | 21 | 50 | 3 | 36332009 | ||
| Pubmed | TUBB1 mutations cause thyroid dysgenesis associated with abnormal platelet physiology. | 4.22e-06 | 22 | 50 | 3 | 30446499 | |
| Pubmed | Identification of alpha-tubulin as an hsp105alpha-binding protein by the yeast two-hybrid system. | 6.07e-06 | 3 | 50 | 2 | 12749852 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 31767681 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 12087096 | ||
| Pubmed | Expression of human alpha-tubulin genes: interspecies conservation of 3' untranslated regions. | 6.07e-06 | 3 | 50 | 2 | 6646120 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 8566014 | ||
| Pubmed | The role of Tuba1a in adult hippocampal neurogenesis and the formation of the dentate gyrus. | 6.07e-06 | 3 | 50 | 2 | 21041996 | |
| Pubmed | [Quantifying gene expression in prostate carcinoma. Which endogenous reference genes are suitable?]. | 6.07e-06 | 3 | 50 | 2 | 17628775 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 9885248 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 19409876 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 11082048 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 11555644 | ||
| Pubmed | 6.08e-06 | 488 | 50 | 7 | 31324722 | ||
| Pubmed | Functional specialization of beta-arrestin interactions revealed by proteomic analysis. | 6.20e-06 | 317 | 50 | 6 | 17620599 | |
| Pubmed | 8.42e-06 | 513 | 50 | 7 | 25798074 | ||
| Pubmed | 9.55e-06 | 197 | 50 | 5 | 23686814 | ||
| Pubmed | 9.95e-06 | 29 | 50 | 3 | 21532586 | ||
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | TUBA1B ACACA TUBA1A RSL1D1 HPRT1 TUBA1C OSGEP GMPPA TUBA4A TUBA3C | 1.01e-05 | 1257 | 50 | 10 | 37317656 |
| Pubmed | 1.05e-05 | 201 | 50 | 5 | 25192599 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 1.08e-05 | 202 | 50 | 5 | 33005030 | |
| Pubmed | HEY1 functions are regulated by its phosphorylation at Ser-68. | 1.09e-05 | 95 | 50 | 4 | 27129302 | |
| Pubmed | 1.18e-05 | 206 | 50 | 5 | 22174317 | ||
| Pubmed | 1.19e-05 | 97 | 50 | 4 | 22360420 | ||
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 12024216 | ||
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 28555754 | ||
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 21858224 | ||
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 9372968 | ||
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 17389232 | ||
| Pubmed | FBXO32 links ubiquitination to epigenetic reprograming of melanoma cells. | 1.36e-05 | 212 | 50 | 5 | 33462405 | |
| Pubmed | 1.49e-05 | 216 | 50 | 5 | 31519766 | ||
| Pubmed | Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition. | 1.54e-05 | 372 | 50 | 6 | 22939624 | |
| Pubmed | 1.56e-05 | 104 | 50 | 4 | 36055981 | ||
| Pubmed | An integrated workflow for charting the human interaction proteome: insights into the PP2A system. | 1.62e-05 | 105 | 50 | 4 | 19156129 | |
| Pubmed | Tuba8 is expressed at low levels in the developing mouse and human brain. | 2.02e-05 | 5 | 50 | 2 | 20466094 | |
| Pubmed | 2.02e-05 | 5 | 50 | 2 | 11826099 | ||
| Pubmed | HDAC-6 interacts with and deacetylates tubulin and microtubules in vivo. | 2.02e-05 | 5 | 50 | 2 | 12606581 | |
| Pubmed | Prefoldin recognition motifs in the nonhomologous proteins of the actin and tubulin families. | 2.02e-05 | 5 | 50 | 2 | 11535601 | |
| Pubmed | 2.02e-05 | 5 | 50 | 2 | 28388629 | ||
| Pubmed | 2.02e-05 | 5 | 50 | 2 | 15129282 | ||
| Pubmed | Five mouse tubulin isotypes and their regulated expression during development. | 2.02e-05 | 5 | 50 | 2 | 3839797 | |
| Pubmed | Viral immune modulators perturb the human molecular network by common and unique strategies. | 2.40e-05 | 116 | 50 | 4 | 22810585 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | TUBA1B ACACA TUBA1A USO1 RSL1D1 HPRT1 TUBA1C SRPK1 KLHDC10 TUBA4A | 2.80e-05 | 1415 | 50 | 10 | 28515276 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | 2.97e-05 | 1425 | 50 | 10 | 30948266 | |
| Pubmed | Parkin binds to alpha/beta tubulin and increases their ubiquitination and degradation. | 3.03e-05 | 6 | 50 | 2 | 12716939 | |
| Pubmed | 3.03e-05 | 6 | 50 | 2 | 11418599 | ||
| Pubmed | 3.03e-05 | 6 | 50 | 2 | 15916950 | ||
| Pubmed | Microtubule binding proteins CLIP-170, EB1, and p150Glued form distinct plus-end complexes. | 3.03e-05 | 6 | 50 | 2 | 16455083 | |
| Pubmed | 3.03e-05 | 6 | 50 | 2 | 16565089 | ||
| Pubmed | Analysis of estrogen receptor alpha signaling complex at the plasma membrane. | 3.03e-05 | 6 | 50 | 2 | 15556606 | |
| Pubmed | Cofilin phosphorylation by LIM-kinase 1 and its role in Rac-mediated actin reorganization. | 3.03e-05 | 6 | 50 | 2 | 9655398 | |
| Pubmed | 3.03e-05 | 6 | 50 | 2 | 7744867 | ||
| Pubmed | The prostate-derived sterile 20-like kinase (PSK) regulates microtubule organization and stability. | 3.03e-05 | 6 | 50 | 2 | 12639963 | |
| Pubmed | 3.03e-05 | 6 | 50 | 2 | 8530437 | ||
| Interaction | TCP11L2 interactions | 4.23e-14 | 21 | 50 | 7 | int:TCP11L2 | |
| Interaction | GRM7 interactions | 8.67e-10 | 19 | 50 | 5 | int:GRM7 | |
| Interaction | TBCB interactions | 1.26e-08 | 114 | 50 | 7 | int:TBCB | |
| Interaction | CD81 interactions | 5.09e-08 | 303 | 50 | 9 | int:CD81 | |
| Interaction | TTC5 interactions | 5.65e-07 | 65 | 50 | 5 | int:TTC5 | |
| Interaction | LTA interactions | 6.57e-07 | 28 | 50 | 4 | int:LTA | |
| Interaction | YWHAQ interactions | TANC2 PTPN3 ACACA TUBA1A USO1 CAMK2A TESK2 TUBA1C EIF5 ADCK2 TUBA3C VCL FBXW7 | 2.28e-06 | 1118 | 50 | 13 | int:YWHAQ |
| Interaction | BSG interactions | TUBA1B TUBA1A CAMK2A TUBA3D HPRT1 TUBA1C TUBA3E TUBA8 TUBA4A TUBA3C | 2.80e-06 | 631 | 50 | 10 | int:BSG |
| Interaction | PFDN6 interactions | 3.72e-06 | 169 | 50 | 6 | int:PFDN6 | |
| Interaction | DNAJA1 interactions | 5.64e-06 | 533 | 50 | 9 | int:DNAJA1 | |
| Interaction | CAPSL interactions | 6.40e-06 | 15 | 50 | 3 | int:CAPSL | |
| Interaction | TRIM28 interactions | TUBA1B TPT1 ZNF562 ACACA STAG1 TUBA1A USO1 RSL1D1 HPRT1 EIF5 PPME1 OSGEP GMPPA TUBA4A | 9.04e-06 | 1474 | 50 | 14 | int:TRIM28 |
| Interaction | INSL5 interactions | 1.29e-05 | 58 | 50 | 4 | int:INSL5 | |
| Interaction | TXNDC9 interactions | 1.38e-05 | 124 | 50 | 5 | int:TXNDC9 | |
| Interaction | CCT3 interactions | TUBA1B ACACA TUBA1A TUBA1C TUBA3E ADGRA2 TUBA4A TUBA3C FBXW7 | 1.54e-05 | 604 | 50 | 9 | int:CCT3 |
| Interaction | SIAH1 interactions | 1.82e-05 | 223 | 50 | 6 | int:SIAH1 | |
| Interaction | ZC2HC1A interactions | 1.91e-05 | 64 | 50 | 4 | int:ZC2HC1A | |
| Interaction | PAK1 interactions | 2.11e-05 | 229 | 50 | 6 | int:PAK1 | |
| Interaction | UBL4A interactions | 2.32e-05 | 349 | 50 | 7 | int:UBL4A | |
| Interaction | STARD13 interactions | 2.43e-05 | 68 | 50 | 4 | int:STARD13 | |
| Interaction | HEY1 interactions | 2.48e-05 | 140 | 50 | 5 | int:HEY1 | |
| Interaction | ADARB1 interactions | 2.49e-05 | 489 | 50 | 8 | int:ADARB1 | |
| Interaction | SHC1 interactions | 2.93e-05 | 362 | 50 | 7 | int:SHC1 | |
| Interaction | MAGED2 interactions | 2.95e-05 | 243 | 50 | 6 | int:MAGED2 | |
| Interaction | BRINP3 interactions | 3.18e-05 | 25 | 50 | 3 | int:BRINP3 | |
| Interaction | CAPS interactions | 3.18e-05 | 25 | 50 | 3 | int:CAPS | |
| Interaction | GZMH interactions | 3.39e-05 | 74 | 50 | 4 | int:GZMH | |
| Interaction | CCDC86 interactions | 3.57e-05 | 151 | 50 | 5 | int:CCDC86 | |
| Interaction | CST11 interactions | 3.58e-05 | 75 | 50 | 4 | int:CST11 | |
| Interaction | GABRA1 interactions | 3.68e-05 | 152 | 50 | 5 | int:GABRA1 | |
| Interaction | DNAJB6 interactions | 3.92e-05 | 379 | 50 | 7 | int:DNAJB6 | |
| Interaction | BRCA1 interactions | DNHD1 ANKRD44 ACACA STAG1 USO1 RSL1D1 HPRT1 TUBA1C PPME1 POMGNT1 TUBA4A VCL | 4.10e-05 | 1249 | 50 | 12 | int:BRCA1 |
| Interaction | FBXO32 interactions | 4.40e-05 | 386 | 50 | 7 | int:FBXO32 | |
| Interaction | ZC2HC1B interactions | 4.51e-05 | 28 | 50 | 3 | int:ZC2HC1B | |
| Interaction | BACE2 interactions | 5.08e-05 | 82 | 50 | 4 | int:BACE2 | |
| Interaction | MAP2K2 interactions | 6.23e-05 | 278 | 50 | 6 | int:MAP2K2 | |
| Interaction | ACE2 interactions | TUBA1B PTPN3 ACACA TUBA1A RSL1D1 HPRT1 TUBA1C TUBA3E SRPK1 TUBA8 TUBA4A | 6.69e-05 | 1106 | 50 | 11 | int:ACE2 |
| Interaction | C9orf72 interactions | TUBA1B ACACA TUBA1A RSL1D1 HPRT1 TUBA1C SRPK1 OSGEP GMPPA TUBA4A TUBA3C VCL | 6.96e-05 | 1319 | 50 | 12 | int:C9orf72 |
| Interaction | PRTN3 interactions | 7.64e-05 | 91 | 50 | 4 | int:PRTN3 | |
| Interaction | ZAP70 interactions | 7.98e-05 | 92 | 50 | 4 | int:ZAP70 | |
| Interaction | CELA3A interactions | 8.15e-05 | 34 | 50 | 3 | int:CELA3A | |
| Interaction | TFCP2 interactions | 9.46e-05 | 436 | 50 | 7 | int:TFCP2 | |
| Interaction | KLK11 interactions | 9.68e-05 | 36 | 50 | 3 | int:KLK11 | |
| Interaction | INSYN2A interactions | 1.23e-04 | 39 | 50 | 3 | int:INSYN2A | |
| Interaction | CD48 interactions | 1.23e-04 | 39 | 50 | 3 | int:CD48 | |
| Interaction | NFXL1 interactions | 1.24e-04 | 103 | 50 | 4 | int:NFXL1 | |
| Interaction | TUBB2A interactions | 1.26e-04 | 316 | 50 | 6 | int:TUBB2A | |
| Interaction | EFNA3 interactions | 1.49e-04 | 108 | 50 | 4 | int:EFNA3 | |
| Interaction | LRRC31 interactions | 1.52e-04 | 205 | 50 | 5 | int:LRRC31 | |
| Interaction | TUBB2B interactions | 1.52e-04 | 205 | 50 | 5 | int:TUBB2B | |
| Interaction | SERBP1 interactions | TUBA1B TUBA1A USO1 HPRT1 TUBA1C EIF5 PPME1 TUBA3E GMPPA TUBA4A TUBA3C FBXW7 | 1.52e-04 | 1432 | 50 | 12 | int:SERBP1 |
| Interaction | NUP210P1 interactions | 1.54e-04 | 42 | 50 | 3 | int:NUP210P1 | |
| Interaction | TUBA1C interactions | 1.67e-04 | 478 | 50 | 7 | int:TUBA1C | |
| Interaction | RPS3A interactions | 1.92e-04 | 655 | 50 | 8 | int:RPS3A | |
| Interaction | ITGAD interactions | 2.02e-04 | 46 | 50 | 3 | int:ITGAD | |
| Interaction | PRSS50 interactions | 2.02e-04 | 46 | 50 | 3 | int:PRSS50 | |
| Interaction | SSR2 interactions | 2.02e-04 | 46 | 50 | 3 | int:SSR2 | |
| Interaction | PLA2G7 interactions | 2.15e-04 | 9 | 50 | 2 | int:PLA2G7 | |
| Interaction | DHDH interactions | 2.16e-04 | 47 | 50 | 3 | int:DHDH | |
| Interaction | NLRP1 interactions | 2.16e-04 | 47 | 50 | 3 | int:NLRP1 | |
| Interaction | RC3H2 interactions | 2.17e-04 | 667 | 50 | 8 | int:RC3H2 | |
| Interaction | SCGB2A2 interactions | 2.24e-04 | 223 | 50 | 5 | int:SCGB2A2 | |
| Interaction | TRAV20 interactions | 2.30e-04 | 48 | 50 | 3 | int:TRAV20 | |
| Interaction | TMPRSS5 interactions | 2.30e-04 | 48 | 50 | 3 | int:TMPRSS5 | |
| Interaction | VAV1 interactions | 2.48e-04 | 228 | 50 | 5 | int:VAV1 | |
| Interaction | A4GNT interactions | 2.59e-04 | 50 | 50 | 3 | int:A4GNT | |
| Interaction | PFDN4 interactions | 2.61e-04 | 125 | 50 | 4 | int:PFDN4 | |
| Interaction | PFN3 interactions | 2.68e-04 | 10 | 50 | 2 | int:PFN3 | |
| Interaction | CKAP2 interactions | 2.69e-04 | 126 | 50 | 4 | int:CKAP2 | |
| Interaction | LPP interactions | 2.77e-04 | 127 | 50 | 4 | int:LPP | |
| Interaction | YAP1 interactions | TUBA1B ACACA TUBA1A TUBA1C TUBA3E TUBA8 TUBA4A TUBA3C VCL FBXW7 | 3.03e-04 | 1095 | 50 | 10 | int:YAP1 |
| Interaction | KCNMB3 interactions | 3.08e-04 | 53 | 50 | 3 | int:KCNMB3 | |
| Interaction | RAD51 interactions | 3.21e-04 | 241 | 50 | 5 | int:RAD51 | |
| Interaction | HSPB1 interactions | 3.24e-04 | 708 | 50 | 8 | int:HSPB1 | |
| Interaction | SPRED1 interactions | 3.26e-04 | 54 | 50 | 3 | int:SPRED1 | |
| Interaction | SERPINB11 interactions | 3.27e-04 | 11 | 50 | 2 | int:SERPINB11 | |
| Interaction | GRAMD2A interactions | 3.27e-04 | 11 | 50 | 2 | int:GRAMD2A | |
| Interaction | TUBB6 interactions | 3.33e-04 | 243 | 50 | 5 | int:TUBB6 | |
| Interaction | TUBB4A interactions | 3.39e-04 | 244 | 50 | 5 | int:TUBB4A | |
| Interaction | TMEM25 interactions | 3.40e-04 | 134 | 50 | 4 | int:TMEM25 | |
| Interaction | LARP7 interactions | TUBA1B ACACA TUBA1A RSL1D1 TUBA1C TUBA3E SRPK1 E4F1 TUBA8 TUBA4A | 3.45e-04 | 1113 | 50 | 10 | int:LARP7 |
| Interaction | PDS5A interactions | 3.46e-04 | 245 | 50 | 5 | int:PDS5A | |
| Interaction | TUBG1 interactions | 3.50e-04 | 382 | 50 | 6 | int:TUBG1 | |
| Interaction | PLD2 interactions | 3.90e-04 | 139 | 50 | 4 | int:PLD2 | |
| Interaction | LGALS2 interactions | 3.92e-04 | 12 | 50 | 2 | int:LGALS2 | |
| Interaction | NXPH3 interactions | 4.03e-04 | 58 | 50 | 3 | int:NXPH3 | |
| Interaction | GML interactions | 4.03e-04 | 58 | 50 | 3 | int:GML | |
| Interaction | LYPD1 interactions | 4.03e-04 | 58 | 50 | 3 | int:LYPD1 | |
| Interaction | LIPH interactions | 4.03e-04 | 58 | 50 | 3 | int:LIPH | |
| Interaction | PTEN interactions | 4.12e-04 | 929 | 50 | 9 | int:PTEN | |
| Interaction | NSUN5P1 interactions | 4.24e-04 | 59 | 50 | 3 | int:NSUN5P1 | |
| Interaction | VHL interactions | 4.41e-04 | 561 | 50 | 7 | int:VHL | |
| Interaction | SLURP1 interactions | 4.46e-04 | 144 | 50 | 4 | int:SLURP1 | |
| Interaction | TIMM50 interactions | 4.62e-04 | 261 | 50 | 5 | int:TIMM50 | |
| Interaction | ITLN1 interactions | 4.67e-04 | 61 | 50 | 3 | int:ITLN1 | |
| Interaction | CST7 interactions | 5.39e-04 | 14 | 50 | 2 | int:CST7 | |
| Interaction | NEK4 interactions | 5.49e-04 | 582 | 50 | 7 | int:NEK4 | |
| Interaction | CDK13 interactions | 5.61e-04 | 153 | 50 | 4 | int:CDK13 | |
| Interaction | DUSP12 interactions | 5.63e-04 | 65 | 50 | 3 | int:DUSP12 | |
| Interaction | NPTN interactions | 6.15e-04 | 278 | 50 | 5 | int:NPTN | |
| Cytoband | 12q13.12 | 9.98e-06 | 38 | 50 | 3 | 12q13.12 | |
| GeneFamily | Tubulins | 1.21e-17 | 26 | 27 | 8 | 778 | |
| Coexpression | NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP | 6.23e-08 | 284 | 50 | 8 | M16975 | |
| Coexpression | TOMIDA_METASTASIS_UP | 1.65e-05 | 26 | 50 | 3 | M17830 | |
| Coexpression | MODY_HIPPOCAMPUS_NEONATAL | 3.42e-05 | 33 | 50 | 3 | M7409 | |
| Coexpression | GSE14308_TH2_VS_INDUCED_TREG_UP | 3.76e-05 | 198 | 50 | 5 | M3366 | |
| Coexpression | GSE41867_DAY8_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_DN | 3.94e-05 | 200 | 50 | 5 | M9492 | |
| Coexpression | GSE42021_CD24HI_VS_CD24LOW_TCONV_THYMUS_UP | 3.94e-05 | 200 | 50 | 5 | M9594 | |
| Coexpression | ALONSO_METASTASIS_EMT_UP | 4.09e-05 | 35 | 50 | 3 | M8191 | |
| Coexpression | RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN | 6.94e-05 | 368 | 50 | 6 | M1859 | |
| Coexpression | XU_GH1_AUTOCRINE_TARGETS_DN | 1.15e-04 | 131 | 50 | 4 | M16384 | |
| ToppCell | (00)_Basal-(4)_1wkpi|(00)_Basal / shred by cell type and Timepoint | 2.03e-06 | 185 | 50 | 5 | bf82ba905e5eee1c39a2731702071d3de10a78b8 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 2.69e-06 | 196 | 50 | 5 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_26.46.91|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.30e-05 | 148 | 50 | 4 | df6bc387cad2f81520bd8bbd009c8e63225dbadb | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_2|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 4.84e-05 | 179 | 50 | 4 | d95367d689732ab2653e8d70d8d8e5eb15ae6eef | |
| ToppCell | ILEUM-non-inflamed-(5)_Plasma-(5)_IgG_plasma_cells|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.85e-05 | 188 | 50 | 4 | 2156f1bc849ff1cb09ae296d13bedd913ae6b43b | |
| ToppCell | Control-PLT_3|World / Disease Group and Platelet Clusters | 5.97e-05 | 189 | 50 | 4 | f65c261fe25479e900d5ed1a0d25a9dec302a57b | |
| ToppCell | (02)_Cycling_Basal_(regeneration)-(1)_24hpi|(02)_Cycling_Basal_(regeneration) / shred by cell type and Timepoint | 5.97e-05 | 189 | 50 | 4 | 311f3aed469be3c8ff913dcc5a2442daa8446d55 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.97e-05 | 189 | 50 | 4 | 965e0e388251e7318f8b463816dc96ccb4658677 | |
| ToppCell | droplet-Bladder-Unstain-18m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.74e-05 | 195 | 50 | 4 | 841fde528ecb293e07b5e00e499d1e9f0b0dce14 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_prolif|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.01e-05 | 197 | 50 | 4 | 61f2c420b77d0527d57532172b07bfb7a4cf971a | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_prolif-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.01e-05 | 197 | 50 | 4 | c395abd57d276e7cb5454cad3afa962fd42059f3 | |
| ToppCell | control-Platelet|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.15e-05 | 198 | 50 | 4 | fc066f428340478605e7d9ff3c0c645c427c4876 | |
| ToppCell | CD8+_Memory_T_cell-FLU-2|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 7.15e-05 | 198 | 50 | 4 | 9813578a58cdedf68b57a0a5e3cf190c9c25a4cd | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.29e-05 | 199 | 50 | 4 | eeb7d370d4dfacf705306c72ccc4919ddefacff1 | |
| ToppCell | FLU-Healthy-4|Healthy / Virus stimulation, Condition and Cluster | 7.29e-05 | 199 | 50 | 4 | 40061131e35131873192ca65c0e731a7b3045636 | |
| ToppCell | tumor_Lung-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | 7.29e-05 | 199 | 50 | 4 | f89d67e3d8cd48ef5c30a5ad71764f4ebbc8bcb3 | |
| ToppCell | MS-IIF-Others-Platelet|IIF / Disease, condition lineage and cell class | 7.44e-05 | 200 | 50 | 4 | 2254319216f1c2e0a0f015ea530c1e6a55a92d5d | |
| ToppCell | Bronchial_Biopsy-Epithelial-Basal_2|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.44e-05 | 200 | 50 | 4 | 99997c447f2b59324fe69c17593db72d972c0cc4 | |
| ToppCell | MS-Multiple_Sclerosis-Others-Platelet|Multiple_Sclerosis / Disease, condition lineage and cell class | 7.44e-05 | 200 | 50 | 4 | 263d956136747c209951b4358f2e1672a21d8eef | |
| Drug | Epothilone D | 7.52e-14 | 12 | 50 | 6 | DB01873 | |
| Drug | Epothilone B | 7.52e-14 | 12 | 50 | 6 | DB03010 | |
| Drug | DTAF | 1.81e-10 | 37 | 50 | 6 | CID000123934 | |
| Drug | bromocolchicine | 8.24e-10 | 21 | 50 | 5 | CID000161518 | |
| Drug | Ustiloxin A | 8.24e-10 | 21 | 50 | 5 | CID000164454 | |
| Drug | SRI-3072 | 8.24e-10 | 21 | 50 | 5 | CID000493469 | |
| Drug | colchifoline | 8.24e-10 | 21 | 50 | 5 | CID000100132 | |
| Drug | 3,4,5-trimethoxyacetophenone | 1.06e-09 | 22 | 50 | 5 | CID000014345 | |
| Drug | AC1L1GIQ | 1.06e-09 | 22 | 50 | 5 | CID000003700 | |
| Drug | 2,4-dichlorobenzyl thiocyanate | 1.06e-09 | 22 | 50 | 5 | CID000098538 | |
| Drug | SureCN13401588 | 1.06e-09 | 22 | 50 | 5 | CID009897422 | |
| Drug | N-methyldemecolcine | 1.06e-09 | 22 | 50 | 5 | CID000023759 | |
| Drug | NSC-339672 | 1.06e-09 | 22 | 50 | 5 | CID000433930 | |
| Drug | IKP104 | 1.36e-09 | 23 | 50 | 5 | CID000130739 | |
| Drug | fluorescein-colchicine | 1.36e-09 | 23 | 50 | 5 | CID003035871 | |
| Drug | 3,4,5-trimethoxybenzaldehyde | 1.36e-09 | 23 | 50 | 5 | CID000006858 | |
| Drug | 3-demethylthiocolchicine | 1.36e-09 | 23 | 50 | 5 | CID000084076 | |
| Drug | 2,3,4-TCB | 1.36e-09 | 23 | 50 | 5 | CID000129239 | |
| Drug | AC1L2P05 | 1.36e-09 | 23 | 50 | 5 | CID000125688 | |
| Drug | 2,3,4-tabp | 1.36e-09 | 23 | 50 | 5 | CID000125548 | |
| Drug | NSC-373301 | 1.36e-09 | 23 | 50 | 5 | CID000341375 | |
| Drug | N-acetylcolchinol | 1.36e-09 | 23 | 50 | 5 | CID000097865 | |
| Drug | NSC355636 | 1.36e-09 | 23 | 50 | 5 | CID000100176 | |
| Drug | TK-B | 1.37e-09 | 51 | 50 | 6 | CID000009074 | |
| Drug | moscatilin | 1.71e-09 | 24 | 50 | 5 | CID000176096 | |
| Drug | parbendazole | 1.71e-09 | 24 | 50 | 5 | CID000026596 | |
| Drug | NSC-36768 | 1.71e-09 | 24 | 50 | 5 | CID000165441 | |
| Drug | deacetamidocolchicine | 1.71e-09 | 24 | 50 | 5 | CID000014995 | |
| Drug | tropolone methyl ether | 1.71e-09 | 24 | 50 | 5 | CID000016546 | |
| Drug | 7-epi-cephalomannine | 1.71e-09 | 24 | 50 | 5 | CID000330401 | |
| Drug | NABV | 1.71e-09 | 24 | 50 | 5 | CID000175959 | |
| Drug | colchicide | 1.71e-09 | 24 | 50 | 5 | CID000120712 | |
| Drug | AC1L4TG7 | 1.71e-09 | 24 | 50 | 5 | CID000163705 | |
| Drug | NSC3096 | 1.89e-09 | 98 | 50 | 7 | CID000002832 | |
| Drug | NBD-colcemid | 2.14e-09 | 25 | 50 | 5 | CID000130594 | |
| Drug | mpMap | 2.14e-09 | 25 | 50 | 5 | CID000100806 | |
| Drug | AC1Q6P06 | 2.14e-09 | 25 | 50 | 5 | CID000160263 | |
| Drug | 2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone | 2.14e-09 | 25 | 50 | 5 | CID000043264 | |
| Drug | allocolchicine | 2.14e-09 | 25 | 50 | 5 | CID000196989 | |
| Drug | 1069C85 | 2.14e-09 | 25 | 50 | 5 | CID006918099 | |
| Drug | 55623-37-5 | 2.14e-09 | 25 | 50 | 5 | CID006438440 | |
| Drug | CA1P | 2.14e-09 | 25 | 50 | 5 | CID006918545 | |
| Drug | peloruside A | 2.14e-09 | 25 | 50 | 5 | CID006918506 | |
| Drug | NSC142227 | 2.14e-09 | 25 | 50 | 5 | CID000073427 | |
| Drug | MDL 27048 | 2.14e-09 | 25 | 50 | 5 | CID006439188 | |
| Drug | NSC527981 | 2.64e-09 | 26 | 50 | 5 | CID000352796 | |
| Drug | NSC332029 | 2.64e-09 | 26 | 50 | 5 | CID000100073 | |
| Drug | indibulin | 2.64e-09 | 26 | 50 | 5 | CID000002929 | |
| Drug | pironetin | 2.64e-09 | 26 | 50 | 5 | CID006438891 | |
| Drug | isaxonine | 2.64e-09 | 26 | 50 | 5 | CID000071169 | |
| Drug | AC1L1J4H | 3.24e-09 | 27 | 50 | 5 | CID000004862 | |
| Drug | NSC292222 | 3.24e-09 | 27 | 50 | 5 | CID000099957 | |
| Drug | dinitroanilines | 3.24e-09 | 27 | 50 | 5 | CID000136400 | |
| Drug | NSC D-669356 | 3.24e-09 | 27 | 50 | 5 | CID000178028 | |
| Drug | NSC 370147 | 3.93e-09 | 28 | 50 | 5 | CID000182762 | |
| Drug | NSC72302 | 3.93e-09 | 28 | 50 | 5 | CID000118078 | |
| Drug | bp U | 4.75e-09 | 29 | 50 | 5 | CID000368697 | |
| Drug | Aids106696 | 4.75e-09 | 29 | 50 | 5 | CID006475933 | |
| Drug | ddGDP | 4.75e-09 | 29 | 50 | 5 | CID000134739 | |
| Drug | oxibendazole | 4.75e-09 | 29 | 50 | 5 | CID000004622 | |
| Drug | PIPES | 5.60e-09 | 64 | 50 | 6 | CID000079723 | |
| Drug | AC1NBBHE | 5.69e-09 | 30 | 50 | 5 | CID004490620 | |
| Drug | eleutherobin | 5.69e-09 | 30 | 50 | 5 | CID006918335 | |
| Drug | azatoxin | 5.69e-09 | 30 | 50 | 5 | CID000125383 | |
| Drug | NSC617668 | 5.69e-09 | 30 | 50 | 5 | CID000357989 | |
| Drug | citostal | 5.69e-09 | 30 | 50 | 5 | CID000018991 | |
| Drug | thiocolchicine | 5.69e-09 | 30 | 50 | 5 | CID000017648 | |
| Drug | tropone | 6.77e-09 | 31 | 50 | 5 | CID000010881 | |
| Drug | NSC609395 | 6.77e-09 | 31 | 50 | 5 | CID005488798 | |
| Drug | amiprophosmethyl | 6.77e-09 | 31 | 50 | 5 | CID000100524 | |
| Drug | AC7700 | 6.77e-09 | 31 | 50 | 5 | CID006918404 | |
| Drug | 3,4-dimethylhexane-2,5-dione | 6.77e-09 | 31 | 50 | 5 | CID000032851 | |
| Drug | AC1L3V8I | 6.77e-09 | 31 | 50 | 5 | CID000122777 | |
| Drug | NSC332598 | 6.77e-09 | 31 | 50 | 5 | CID000615942 | |
| Drug | N,N'-ethylenebis(iodoacetamide | 6.77e-09 | 31 | 50 | 5 | CID000023678 | |
| Drug | AC1L1G95 | 8.01e-09 | 32 | 50 | 5 | CID000003583 | |
| Drug | E2-3,4-Q | 8.01e-09 | 32 | 50 | 5 | CID000067402 | |
| Drug | NSC153858 | 8.01e-09 | 32 | 50 | 5 | CID000547450 | |
| Drug | 2-demethylcolchicine | 8.01e-09 | 32 | 50 | 5 | CID000023757 | |
| Drug | CA4P | 9.42e-09 | 33 | 50 | 5 | CID000370232 | |
| Drug | taltobulin | 9.42e-09 | 33 | 50 | 5 | CID006918637 | |
| Drug | mebendazole | 9.42e-09 | 33 | 50 | 5 | CID000004030 | |
| Drug | triethyllead | 1.10e-08 | 34 | 50 | 5 | CID006328106 | |
| Drug | NSC376450 | 1.10e-08 | 34 | 50 | 5 | CID000005605 | |
| Drug | 2-phenyl-4-quinolone | 1.10e-08 | 34 | 50 | 5 | CID000161091 | |
| Drug | discodermolide | 1.28e-08 | 35 | 50 | 5 | CID000643668 | |
| Drug | AC1O5Y0F | 1.72e-08 | 37 | 50 | 5 | CID006442852 | |
| Drug | albendazole | 1.72e-08 | 37 | 50 | 5 | CID000002082 | |
| Drug | baccatin III | 1.72e-08 | 37 | 50 | 5 | CID000065366 | |
| Drug | laulimalide | 1.98e-08 | 38 | 50 | 5 | CID006918457 | |
| Drug | gnoscopine | 1.98e-08 | 38 | 50 | 5 | CID000004544 | |
| Drug | colchiceine | 1.98e-08 | 38 | 50 | 5 | CID000010156 | |
| Drug | erianin | 2.26e-08 | 39 | 50 | 5 | CID000356759 | |
| Drug | Dolastatin 10 | 2.26e-08 | 39 | 50 | 5 | CID000100208 | |
| Drug | AC1L8GZ1 | 2.58e-08 | 40 | 50 | 5 | CID000381235 | |
| Drug | indanone | 2.94e-08 | 41 | 50 | 5 | CID000006735 | |
| Drug | amoebal | 2.94e-08 | 41 | 50 | 5 | CID000001985 | |
| Drug | lumicolchicine | 2.94e-08 | 41 | 50 | 5 | CID000072624 | |
| Drug | AC1L9CY0 | 3.76e-08 | 43 | 50 | 5 | CID000396644 | |
| Drug | Stylophorin | 3.76e-08 | 43 | 50 | 5 | CID000010147 | |
| Disease | polymicrogyria (implicated_via_orthology) | 2.65e-23 | 8 | 48 | 8 | DOID:0080918 (implicated_via_orthology) | |
| Disease | microlissencephaly (implicated_via_orthology) | 2.65e-23 | 8 | 48 | 8 | DOID:0112234 (implicated_via_orthology) | |
| Disease | lissencephaly 3 (implicated_via_orthology) | 2.65e-23 | 8 | 48 | 8 | DOID:0112232 (implicated_via_orthology) | |
| Disease | lissencephaly (implicated_via_orthology) | 5.75e-17 | 27 | 48 | 8 | DOID:0050453 (implicated_via_orthology) | |
| Disease | lissencephaly (is_implicated_in) | 2.58e-05 | 5 | 48 | 2 | DOID:0050453 (is_implicated_in) | |
| Disease | Hepatic Form of Wilson Disease | 6.99e-04 | 24 | 48 | 2 | C1527352 | |
| Disease | Hepatolenticular Degeneration | 6.99e-04 | 24 | 48 | 2 | C0019202 | |
| Disease | Intellectual Disability | 7.82e-04 | 447 | 48 | 5 | C3714756 | |
| Disease | immature platelet measurement | 9.69e-04 | 119 | 48 | 3 | EFO_0803541 | |
| Disease | Acute Coronary Syndrome | 1.32e-03 | 33 | 48 | 2 | C0948089 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VMGQGQRVAELILHH | 516 | Q7Z695 | |
| LHCQHLGNVAVLMEL | 741 | Q96PE1 | |
| VVCLQQVCHQIGDMG | 106 | P35670 | |
| GQLHHIMINREEGVV | 1101 | Q9C0A0 | |
| GIQIMHNNGVTHCTV | 1871 | Q13085 | |
| HGQLSHVPCVENMIQ | 566 | Q96M86 | |
| GQVLLDMVHNHLGVT | 51 | P26045 | |
| MQVLPQCGHAVHEDA | 341 | Q9Y570 | |
| KAGGMHHICIEVDNI | 116 | Q96PE7 | |
| CMYIHGGVVNIHENK | 376 | Q6PID8 | |
| ALHRGIMTGHEECVQ | 706 | Q8N8A2 | |
| QEVCGNLTLQHHMLE | 281 | Q5JSP0 | |
| IIQHEMDHLQGCLFI | 211 | Q9HBH1 | |
| GVNHCIGHIEMGRLI | 106 | Q9NPF4 | |
| EMGGHHIVALCVLKG | 56 | P00492 | |
| VAGVPMIQHHIEACA | 31 | Q96IJ6 | |
| HGLECVVAMHQAQLI | 316 | P55010 | |
| MQEQVHVLGVGLAVH | 1586 | Q8IZD9 | |
| GQCLHVLMGHVAAVR | 491 | Q969H0 | |
| HVQLLCINCMVAVGH | 551 | Q96C10 | |
| HIIMGHVQLVDVCTF | 321 | Q49MI3 | |
| EVGQLLQQHMECAIG | 731 | P57679 | |
| VIHEVHVQMQELSLG | 331 | Q66K89 | |
| EHCGVHMVLQVPQES | 281 | Q95460 | |
| EVGIQAMEHLIHVLQ | 56 | O60763 | |
| MGHPGIDIHTVCVQN | 946 | Q9P212 | |
| IHVIVLNQATGHVMA | 131 | Q8WZA1 | |
| VVQFLVDHGAMIEHV | 1181 | Q9HCD6 | |
| VNGTHICMVFEVLGH | 156 | Q96SB4 | |
| IQQILEAVLHCHQMG | 116 | Q9UQM7 | |
| RISGVNGVHVCMVLE | 151 | Q9UPE1 | |
| NGVHVCMVLEVLGHQ | 156 | Q9UPE1 | |
| MRECISIHVGQAGVQ | 1 | P0DPH8 | |
| NHMGIHIGEKLCEFQ | 221 | Q6V9R5 | |
| CVGHDQHMVSQLIGT | 71 | Q9UHI7 | |
| HIRLGMGHVLIIVQC | 226 | Q9BS91 | |
| CSAIRIGHVGMQIEH | 211 | O76021 | |
| IGHVGMQIEHIIENI | 216 | O76021 | |
| VITGVDIVMNHHLQE | 66 | P13693 | |
| MRECISIHVGQAGVQ | 1 | P0DPH7 | |
| IQEHVQHGLMVDLNG | 686 | Q92626 | |
| VAQQISHLVIMHEEG | 16 | P18206 | |
| HGAMPEQIVVQALQC | 726 | Q8WVM7 | |
| MGVCVHQGQLHALTE | 116 | Q15569 | |
| MRECISIHVGQAGVQ | 1 | Q71U36 | |
| MRECISIHVGQAGVQ | 1 | Q6PEY2 | |
| LGIELHCNVSNILHM | 206 | Q96N95 | |
| FMGVCVHQGQLHALT | 116 | Q96S53 | |
| MRECISIHVGQAGVQ | 1 | P68363 | |
| MRECISIHVGQAGVQ | 1 | Q9BQE3 | |
| MRECISVHVGQAGVQ | 1 | Q9NY65 | |
| MRECISVHVGQAGVQ | 1 | P68366 |